A phase III open clinical study of SJP-0118 in patients who schedule intraocular surgery - An open clinical study in patients who schedule intraocular surgery

Senju Pharmaceutical Co.,Ltd.0 个研究点目标入组 150 人开始时间: 2017年3月17日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Scheduled ocular surgery in the opposite eye to the treated eye during the study period 2) Possible ocular infection in the treated eye judged by clinical findings 3) Any history of recurrent erosion of cornea, particularly corneal ulcer, in the treated eye 4) Corneal findings of "+" or worse in the treated eye 5) Use of any antibiotic or synthetic antibacterial agent one week prior to the start of treatment (systemic, ocular instillation in either eye or topical dermal application around eyes) 6) Any history of ocular surgery in the treated eye within 90 days prior to the start of study treatment 7) Presence of a cancer or a serious systemic disease such as serious hepatic disorder, serious renal disorder, serious cardiovascular disease or serious endocrine system disease 8) Known history of allergy or significant adverse drug reaction to any ingredients of the drugs used in this study (e.g. fluorescein, and so on), azithromycin or other macrolide antibiotics 9) Past ocular instillation of azithromycin

发起方